Thyroid Eye Disease, TED Clinical Trials

12 clinical trials for Thyroid Eye Disease, TED across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED) — RECRUITING · PHASE3
• A Clinical Study of Cizutamig in Thyroid Eye Disease — RECRUITING · PHASE1
• Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease — RECRUITING · NA
• Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease — RECRUITING · PHASE2
• Treatment of Chronic Thyroid Eye Disease With MHB018A — NOT_YET_RECRUITING · PHASE3
• Treatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled Study — NOT_YET_RECRUITING · PHASE3
• Teprotumumab N01 Versus Methylprednisolone After Urgent Orbital Decompression for Dysthyroid Optic Neuropathy — NOT_YET_RECRUITING · PHASE2
• A Multicenter, Open-label Extension Study Evaluating the Efficacy and Safety of IBI311 in Subjects With Thyroid Eye Disease — COMPLETED · PHASE3
• Triamcinolone Acetonide Injection for Upper Eyelid Retraction in Thyroid Eye Disease — COMPLETED · NA
• Psychological Burden of Thyroid Eye Disease — COMPLETED
• Comparison of the Efficacy and Safety of 4 vs. 8 Treatments With Tepezza (Teprotumumab) for Thyroid Eye Disease — NOT_YET_RECRUITING · PHASE4
• Multi-modal Medical Images for Extraocular Muscle Fibrosis Assessment — COMPLETED

Refine this search